DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1ACETAMINOPHEN
02 1ACTOPLUS MET XR
03 1ALBUTEROL SULFATE
04 1ALTOPREV
05 2BUPROPION HYDROCHLORIDE
06 1CIPROFLOXACIN EXTENDED RELEASE
07 7CLONIDINE HYDROCHLORIDE
08 1DICLOFENAC SODIUM
09 1DYANAVEL XR 10
10 1DYANAVEL XR 15
11 1DYANAVEL XR 20
12 1DYANAVEL XR 5
13 1ETODOLAC
14 1FLUVASTATIN SODIUM
15 1FORTAMET
16 1GUANFACINE HYDROCHLORIDE
17 1HORIZANT
18 1JENLOGA
19 1KAPVAY
20 3LEVETIRACETAM
21 5LITHIUM CARBONATE
22 1LITHOBID
23 1LORATADINE AND PSEUDOEPHEDRINE SULFATE
24 4METFORMIN HYDROCHLORIDE
25 1METHYLPHENIDATE HYDROCHLORIDE
26 1MOXATAG
27 3NIFEDIPINE
28 1ORENITRAM
29 1OXYBUTYNIN CHLORIDE
30 1PAXIL CR
31 3POTASSIUM CHLORIDE
32 6RANOLAZINE
33 1RYZOLT
34 1SULAR
35 1TEGRETOL-XR
36 2VENLAFAXINE HYDROCHLORIDE
37 1VERAPAMIL HYDROCHLORIDE
38 1ZILEUTON
39 2ZOLPIDEM TARTRATE
01 118027
02 120234
03 120356
04 120936
05 121316
06 121574
07 121745
08 122024
09 222331
10 122399
11 150813
12 174587
13 175269
14 175289
15 175665
16 175706
17 176070
18 176152
19 176200
20 176368
21 176832
22 177285
23 178092
24 178179
25 178183
26 190153
27 191093
28 191272
29 191544
30 1201408
31 1202167
32 1202288
33 1202458
34 1202917
35 1202984
36 1203059
37 1203320
38 1203496
39 1203755
40 1204779
41 1205532
42 1206556
43 1206630
44 1207138
45 1208607
46 1209193
47 1209285
48 1209757
49 1209993
50 1210052
51 4210526
52 1210680
53 1211291
54 1211390
55 1211433
56 1211829
57 1211865
58 1212561
59 1212889
60 1213085
61 1213247
62 1213517
01 58No
02 8Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : CLONIDINE HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 210680
Country : US
Patented : No
Drug : POTASSIUM CHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 76368
Country : US
Patented : No
Drug : JENLOGA
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 22331
Country : US
Patented : No
Drug : KAPVAY
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 22331
Country : US
Patented : No
Drug : LITHIUM CARBONATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 91544
Country : US
Patented : No
Drug : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 212889
Country : US
Patented : No
CIPROFLOXACIN; CIPROFLOXACIN HYDROCHLORIDE
Drug : CIPROFLOXACIN EXTENDED RELEASE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78183
Country : US
Patented : No
Drug : ALBUTEROL SULFATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78092
Country : US
Patented : No
Drug : VERAPAMIL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 74587
Country : US
Patented : No
Drug : LEVETIRACETAM
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202167
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
